Technology & ScienceNVIDIA's BioNeMo Becomes Global Drug Discovery's Default AI Infrastructure as Big Pharma Cedes Biology to SpecialistsSalvado•May 21, 2026
Technology & ScienceNVIDIA Locks In Eli Lilly and Thermo Fisher as BioNeMo Becomes Global Pharma AI BackboneSalvado•May 1, 2026
Technology & InnovationNVIDIA Secures Thermo Fisher and Eli Lilly as Global Biotech AI Platform Race IntensifiesSalvado•Apr 29, 2026
Healthcare TechnologyNVIDIA Secures Eli Lilly and Thermo Fisher for BioNeMo Drug Discovery Platform as Pharma AI Infrastructure ConsolidatesSalvado•Apr 17, 2026
Health & MedicineNVIDIA's BioNeMo Platform Reaches Eli Lilly and Thermo Fisher in Global Pharma AI PushSalvado•Apr 13, 2026
biotechnologyNVIDIA BioNeMo Wins Lilly, Thermo Fisher Deals as Global Biotech AI Platform Race AcceleratesSalvado•Apr 12, 2026
biotechnologyNVIDIA BioNeMo Secures Eli Lilly and Thermo Fisher as Platform Wars Erupt in Global Pharma AISalvado•Apr 9, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Deployed by Global Pharma Giants for AI Drug Discovery in 2026Salvado•Apr 9, 2026
Healthcare TechnologyNVIDIA's AI Platform Powers Drug Discovery at Thermo Fisher, Eli Lilly in $1.6 Trillion Pharma Market PushSalvado•Mar 25, 2026
Science & TechnologyNVIDIA's BioNeMo Aims to Become the Global Infrastructure Layer for Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Bets on Becoming the Global Infrastructure Layer for Pharmaceutical AIViaNews Editorial Team•Feb 18, 2026
